YK-3-237

Overview

YK-3-237, a SIRT1 activator , targets mutant p53. YK-3-237 inhibits the proliferation of triple-negative breast cancer cells.

Application

Products | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Obesity | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Sirtuin

Product Information

• Catalog No.: HY-19634
• CAS No.: 1215281-19-8
• Molecular Formula: C19H21BO7
• Molecular Weight: 372.18
• Purity: 99.54%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (6.72 mM); Clear solution
• Availability: In-stock

Source

Original product source